A

Abeona Therapeutics

D
ABEO
USD
-0.15
(-2.459%)
Market Closed
23,563.00
حجم التداول
-1.75
الربح لكل سهم
-
العائد الربحي
-3.361582
P/E
257,720,662.15
حجم السوق
اليوم
-2.4590%
1 اسبوع
-6.740%
1 شهر
-5.104%
6 اشهر
41.330%
12 اشهر
38.051%
بداية السنة
18.762%
كل الوقت
0%
avatar
sara abdelazim
عدد النقاط
112
عدد التوصيات
2

Title:
Abeona Therapeutics

Sector:
Healthcare
Industry:
Biotechnology
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.
هل تحتاج مساعدة او لديك استفسار؟